These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 23570537)

  • 21. Stable expression, activity, and inducibility of cytochromes P450 in differentiated HepaRG cells.
    Anthérieu S; Chesné C; Li R; Camus S; Lahoz A; Picazo L; Turpeinen M; Tolonen A; Uusitalo J; Guguen-Guillouzo C; Guillouzo A
    Drug Metab Dispos; 2010 Mar; 38(3):516-25. PubMed ID: 20019244
    [TBL] [Abstract][Full Text] [Related]  

  • 22. An 'all-inclusive' 96-well cytochrome P450 induction method: measuring enzyme activity, mRNA levels, protein levels, and cytotoxicity from one well using cryopreserved human hepatocytes.
    Halladay JS; Wong S; Khojasteh SC; Grepper S
    J Pharmacol Toxicol Methods; 2012; 66(3):270-5. PubMed ID: 22809809
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [The combined effect of isoniazid and rifampicin on the activities of CYP4501A2 and CYP4503A4 in primary hepatocytes from healthy human adults].
    Liu ZW; Hu ZH; Cai YY
    Zhonghua Jie He He Hu Xi Za Zhi; 2005 Nov; 28(11):785-8. PubMed ID: 16324277
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Predicting carrier-mediated hepatic disposition of rosuvastatin in man by scaling from individual transfected cell-lines in vitro using absolute transporter protein quantification and PBPK modeling.
    Bosgra S; van de Steeg E; Vlaming ML; Verhoeckx KC; Huisman MT; Verwei M; Wortelboer HM
    Eur J Pharm Sci; 2014 Dec; 65():156-66. PubMed ID: 25261337
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Induction of CYP3A4 by efavirenz in primary human hepatocytes: comparison with rifampin and phenobarbital.
    Hariparsad N; Nallani SC; Sane RS; Buckley DJ; Buckley AR; Desai PB
    J Clin Pharmacol; 2004 Nov; 44(11):1273-81. PubMed ID: 15496645
    [TBL] [Abstract][Full Text] [Related]  

  • 26. In vitro evaluation of hepatotoxic drugs in human hepatocytes from multiple donors: Identification of P450 activity as a potential risk factor for drug-induced liver injuries.
    Utkarsh D; Loretz C; Li AP
    Chem Biol Interact; 2016 Aug; 255():12-22. PubMed ID: 26718876
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Temporal kinetics and concentration-response relationships for induction of CYP1A, CYP2B, and CYP3A in primary cultures of beagle dog hepatocytes.
    Graham RA; Tyler LO; Krol WL; Silver IS; Webster LO; Clark P; Chen L; Banks T; LeCluyse EL
    J Biochem Mol Toxicol; 2006; 20(2):69-78. PubMed ID: 16615094
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Evaluation of the Interplay between Uptake Transport and CYP3A4 Induction in Micropatterned Cocultured Hepatocytes.
    Moore A; Chothe PP; Tsao H; Hariparsad N
    Drug Metab Dispos; 2016 Dec; 44(12):1910-1919. PubMed ID: 27655038
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Regulation of cytochrome P450 2C9 expression in primary cultures of human hepatocytes.
    Sahi J; Shord SS; Lindley C; Ferguson S; LeCluyse EL
    J Biochem Mol Toxicol; 2009; 23(1):43-58. PubMed ID: 19202563
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Comparative study of culture conditions for maintaining CYP3A4 and ATP-binding cassette transporters activity in primary cultured human hepatocytes.
    Takeba Y; Matsumoto N; Takenoshita-Nakaya S; Harimoto Y; Kumai T; Kinoshita Y; Nakano H; Ohtsubo T; Kobayashi S
    J Pharmacol Sci; 2011; 115(4):516-24. PubMed ID: 21436605
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Functional characterization of mouse organic anion transporting peptide 1a4 in the uptake and efflux of drugs across the blood-brain barrier.
    Ose A; Kusuhara H; Endo C; Tohyama K; Miyajima M; Kitamura S; Sugiyama Y
    Drug Metab Dispos; 2010 Jan; 38(1):168-76. PubMed ID: 19833843
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Assessment of cytochrome P450 (1A2, 2B6, 2C9 and 3A4) induction in cryopreserved human hepatocytes cultured in 48-well plates using the cocktail strategy.
    Gerin B; Dell'Aiera S; Richert L; Smith S; Chanteux H
    Xenobiotica; 2013 Apr; 43(4):320-35. PubMed ID: 23153057
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Comparison of the inducibility of CYP mRNA exposed to typical inducers in fresh and cryopreserved cynomolgus monkey hepatocytes.
    Koeda A; Iwao T; Nakanishi A; Mizuno S; Yamashita M; Sakai Y; Nakamura K; Matsunaga T
    Drug Metab Pharmacokinet; 2020 Jun; 35(3):304-312. PubMed ID: 32303457
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Determination of cytochrome P450 1A2 and cytochrome P450 3A4 induction in cryopreserved human hepatocytes.
    Roymans D; Van Looveren C; Leone A; Parker JB; McMillian M; Johnson MD; Koganti A; Gilissen R; Silber P; Mannens G; Meuldermans W
    Biochem Pharmacol; 2004 Feb; 67(3):427-37. PubMed ID: 15037195
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Induction of influx and efflux transporters and cytochrome P450 3A4 in primary human hepatocytes by rifampin, rifabutin, and rifapentine.
    Williamson B; Dooley KE; Zhang Y; Back DJ; Owen A
    Antimicrob Agents Chemother; 2013 Dec; 57(12):6366-9. PubMed ID: 24060875
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Direct transcriptional regulation of human hepatic cytochrome P450 3A4 (CYP3A4) by peroxisome proliferator-activated receptor alpha (PPARα).
    Thomas M; Burk O; Klumpp B; Kandel BA; Damm G; Weiss TS; Klein K; Schwab M; Zanger UM
    Mol Pharmacol; 2013 Mar; 83(3):709-18. PubMed ID: 23295386
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Comparison of immortalized Fa2N-4 cells and human hepatocytes as in vitro models for cytochrome P450 induction.
    Hariparsad N; Carr BA; Evers R; Chu X
    Drug Metab Dispos; 2008 Jun; 36(6):1046-55. PubMed ID: 18332078
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Bosentan is a substrate of human OATP1B1 and OATP1B3: inhibition of hepatic uptake as the common mechanism of its interactions with cyclosporin A, rifampicin, and sildenafil.
    Treiber A; Schneiter R; Häusler S; Stieger B
    Drug Metab Dispos; 2007 Aug; 35(8):1400-7. PubMed ID: 17496208
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Effect of Gevokizumab on Interleukin-1β-Mediated Cytochrome P450 3A4 and Drug Transporter Repression in Cultured Human Hepatocytes.
    Moreau A; Le Vée M; Jouan E; Denizot C; Parmentier Y; Fardel O
    Eur J Drug Metab Pharmacokinet; 2017 Oct; 42(5):871-878. PubMed ID: 28260174
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Janus kinase-dependent regulation of drug detoxifying protein expression by interleukin-22 in human hepatic cells.
    Le Vée M; Bruyère A; Jouan E; Fardel O
    Int Immunopharmacol; 2020 Jun; 83():106439. PubMed ID: 32234672
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.